• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外致突变结合和抗突变活性的人鼠李糖乳杆菌 231。

In vitro mutagen binding and antimutagenic activity of human Lactobacillus rhamnosus 231.

机构信息

Department of Biosciences, Saurashtra University, Rajkot, India.

出版信息

Anaerobe. 2011 Oct;17(5):217-22. doi: 10.1016/j.anaerobe.2011.07.001. Epub 2011 Jul 12.

DOI:10.1016/j.anaerobe.2011.07.001
PMID:21777684
Abstract

In vitro mutagen binding ability of human Lactobacillus rhamnosus 231 (Lr 231) was evaluated against acridine orange (AO), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), 2-amino-3, 8-dimethylimidazo-[4,5-f]-quinoxaline (MeIQx) and 4-nitro-o-phenylenediamine (NPD). Binding of AO by Lr 231 is due to adsorption, thereby leading to removal of mutagen in solution and is instantaneous, pH- and concentration-dependent. Whereas, binding of MNNG and MeIQx by Lr 231 results into biotransformation leading to detoxification with subsequent loss of mutagenicity as determined by spectral analysis, thin layer chromatography and Ames test. Binding of mutagen by Lr 231 was dependent on culture age and optimum binding of AO, MNNG and MeIQx was observed to occur with 24 h old culture. Cells of Lr 231 were subjected to different chemical treatments prior to binding studies. Results indicated cell wall component such as cell wall polysaccharide, peptidoglycan, carbohydrates and proteins plays an important role in adsorption of AO, also involving hydrophilic and ionic interactions. Binding, biotransformation and detoxification of MNNG and MeIQx by Lr 231 was dependent on cell surface characteristics mainly involving carbohydrates, proteins, teichoic acid/lipoteichoic acid, hydrophobic interaction and presence of thiol group. L. rhamnosus 231 bound MNNG instantaneously. More than 96 (p < 0.01) and 70% (p < 0.05) cells remained viable after mutagen binding and various pretreatments respectively. This study shows Lr 231 exhibits ability to bind and detoxify potent mutagens, and this property can be useful in formulating fermented foods for removal of potent mutagens.

摘要

我们评估了人源鼠李糖乳杆菌 231(Lr 231)对吖啶橙(AO)、N-甲基-N'-硝基-N-亚硝胍(MNNG)、2-氨基-3,8-二甲基咪唑[4,5-f]-喹喔啉(MeIQx)和 4-硝基邻苯二胺(NPD)的体外致突变结合能力。Lr 231 对 AO 的结合是由于吸附作用,从而导致溶液中的致突变剂被去除,且该过程是瞬时的,依赖于 pH 值和浓度。然而,Lr 231 对 MNNG 和 MeIQx 的结合导致生物转化,从而解毒,随后通过光谱分析、薄层层析和艾姆斯试验确定致突变性丧失。Lr 231 对致突变剂的结合依赖于培养年龄,对 AO、MNNG 和 MeIQx 的最佳结合观察到发生在 24 小时龄的培养物中。在结合研究之前,将 Lr 231 的细胞进行了不同的化学处理。结果表明,细胞壁成分,如细胞壁多糖、肽聚糖、碳水化合物和蛋白质,在 AO 的吸附中发挥重要作用,同时涉及亲水和离子相互作用。Lr 231 对 MNNG 和 MeIQx 的结合、生物转化和解毒依赖于细胞表面特性,主要涉及碳水化合物、蛋白质、磷壁酸/脂磷壁酸、疏水相互作用和巯基的存在。L. rhamnosus 231 能瞬时结合 MNNG。在致突变结合和各种预处理后,分别有超过 96%(p < 0.01)和 70%(p < 0.05)的细胞保持存活。这项研究表明,Lr 231 具有结合和解毒潜在致突变剂的能力,这种特性可用于配制发酵食品以去除潜在致突变剂。

相似文献

1
In vitro mutagen binding and antimutagenic activity of human Lactobacillus rhamnosus 231.体外致突变结合和抗突变活性的人鼠李糖乳杆菌 231。
Anaerobe. 2011 Oct;17(5):217-22. doi: 10.1016/j.anaerobe.2011.07.001. Epub 2011 Jul 12.
2
Antigenotoxic and Antimutagenic Activities of Probiotic Lactobacillus rhamnosus Vc against N-Methyl-N'-Nitro-N-Nitrosoguanidine.益生菌鼠李糖乳杆菌Vc对N-甲基-N'-硝基-N-亚硝基胍的抗遗传毒性和抗诱变活性
Nutr Cancer. 2015;67(7):1142-50. doi: 10.1080/01635581.2015.1073751. Epub 2015 Aug 27.
3
Protective effect of Lactobacillus rhamnosus 231 against N-Methyl-N'-nitro-N-nitrosoguanidine in animal model.鼠李糖乳杆菌 231 对动物模型中 N-甲基-N'-硝基-N-亚硝胍的保护作用。
Gut Microbes. 2011 Nov-Dec;2(6):319-25. doi: 10.4161/gmic.18755. Epub 2011 Nov 1.
4
Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.2-氨基-3,8-二甲基咪唑并[4,5-f]喹喔啉在人肝细胞中的代谢:2-氨基-3-甲基咪唑并[4,5-f]喹喔啉-8-羧酸是由细胞色素P450 1A2催化的主要解毒途径。
Chem Res Toxicol. 2001 Feb;14(2):211-21. doi: 10.1021/tx000176e.
5
Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.人及大鼠肝微粒体和细胞色素P450 1A2对2-氨基-3,8-二甲基咪唑并[4,5-f]喹喔啉进行C(8)位和N位氧化的区域选择性差异
Chem Res Toxicol. 2001 Jul;14(7):901-11. doi: 10.1021/tx010035s.
6
The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes.N-氧化作用对大鼠肝细胞中食源性致癌物2-氨基-3,8-二甲基咪唑[4,5-f]喹喔啉代谢的贡献。
Chem Res Toxicol. 1990 Nov-Dec;3(6):524-35. doi: 10.1021/tx00018a006.
7
Mutagenic metabolites in urine and feces of rats fed with 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, a carcinogenic mutagen present in cooked meat.给大鼠喂食2-氨基-3,8-二甲基咪唑并[4,5-f]喹喔啉(一种存在于熟肉中的致癌诱变剂)后,大鼠尿液和粪便中的诱变代谢物。
Cancer Res. 1987 Feb 1;47(3):791-4.
8
Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).新型亲脂性抗氧化剂1-O-己基-2,3,5-三甲基对苯二酚在Ames试验中对杂环胺诱导的诱变具有很强的抗诱变活性及其对2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑(Glu-p-1)代谢活化的影响。
Carcinogenesis. 1995 Sep;16(9):2227-32. doi: 10.1093/carcin/16.9.2227.
9
Disposition and metabolism of the food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rats.食物诱变剂2-氨基-3,8-二甲基咪唑并[4,5-f]喹喔啉(MeIQx)在大鼠体内的处置与代谢
Carcinogenesis. 1989 Jul;10(7):1269-75. doi: 10.1093/carcin/10.7.1269.
10
The effect of fibre source and fermentation on the apparent hydrophobic binding properties of wheat bran preparations for the mutagen 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline (MeIQx).纤维来源和发酵对麦麸制品与诱变剂2-氨基-3,8-二甲基咪唑并[4,5-f]喹喔啉(MeIQx)的表观疏水结合特性的影响。
Carcinogenesis. 1995 Feb;16(2):209-16. doi: 10.1093/carcin/16.2.209.

引用本文的文献

1
The Anti-Inflammatory, Immunomodulatory, and Pro-Autophagy Activities of Probiotics for Colorectal Cancer Prevention and Treatment: A Narrative Review.益生菌在预防和治疗结直肠癌中的抗炎、免疫调节及促自噬活性:一项叙述性综述
Biomedicines. 2025 Jun 25;13(7):1554. doi: 10.3390/biomedicines13071554.
2
The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies.微生物群的促癌和抑癌作用及其在抗癌治疗策略中的作用
Cancers (Basel). 2022 Dec 28;15(1):190. doi: 10.3390/cancers15010190.
3
Antimutagenic Activity as a Criterion of Potential Probiotic Properties.
抗诱变活性作为潜在益生菌特性的一个标准。
Probiotics Antimicrob Proteins. 2022 Dec;14(6):1094-1109. doi: 10.1007/s12602-021-09870-9. Epub 2022 Jan 14.
4
Postbiotics as Promising Tools for Cancer Adjuvant Therapy.后生元作为癌症辅助治疗的有前景工具
Adv Pharm Bull. 2021 Jan;11(1):1-5. doi: 10.34172/apb.2021.007. Epub 2020 Nov 7.
5
Safety evaluation of multiple strains of Lactobacillus plantarum and Pediococcus pentosaceus in Wistar rats based on the Ames test and a 28-day feeding study.基于艾姆斯试验和28天喂养研究对Wistar大鼠体内多种植物乳杆菌和戊糖片球菌菌株的安全性评估。
ScientificWorldJournal. 2014;2014:928652. doi: 10.1155/2014/928652. Epub 2014 Oct 14.
6
Insight into the Draft Genome Sequence of Human Isolate Lactobacillus rhamnosus LR231, a Bacterium with Probiotic Potential.对具有益生菌潜力的人源分离株鼠李糖乳杆菌LR231基因组序列草图的解析。
Genome Announc. 2014 Feb 27;2(1):e00111-14. doi: 10.1128/genomeA.00111-14.
7
Genotoxicity assessment of multispecies probiotics using reverse mutation, mammalian chromosomal aberration, and rodent micronucleus tests.使用回复突变试验、哺乳动物染色体畸变试验和啮齿动物微核试验对多种益生菌进行遗传毒性评估。
ScientificWorldJournal. 2013 Oct 23;2013:254239. doi: 10.1155/2013/254239. eCollection 2013.
8
Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer.益生菌、益生元和合生制剂在结直肠癌治疗中的潜力。
Gut Microbes. 2013 May-Jun;4(3):181-92. doi: 10.4161/gmic.23919. Epub 2013 Mar 19.